Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nevis Brands Inc C.NEVI

Alternate Symbol(s):  NEVIF

Consumer Defensive Household & Personal Products
Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience... see more

Recent & Breaking News (CSE:NEVI)

Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration

GlobeNewswire June 18, 2018

Pascal Announces Oversubscription of Financing

GlobeNewswire March 8, 2018

Pascal Biosciences Inc. Announces Non-Brokered Private Placement

GlobeNewswire February 23, 2018

Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells

GlobeNewswire February 21, 2018

Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell

GlobeNewswire December 5, 2017

Pascal Biosciences Acquires Technology to Treat Leukemia from the University of New Mexico

GlobeNewswire September 11, 2017

Pascal Biosciences Creates Development Science Lab in Seattle WA

MarketWire Canada May 9, 2017